Pharma Limited on Thursday announced that it has received final approval from the US Food and Drug Administration (FDA) for generic
version of budesonide
capsule (enteric coated) 3 mg. Natco
and its marketing partner Alvogen plan to launch this product in the US immediately.
The approved product is the generic
version of Perrigo Pharma’s Entocort
EC capsule. According to IMS Health, Entocort
EC capsule (3 mg) and its generic
versions had US sales of approximately $ 370 million for twelve months ending December 2015.
is a gastroenterology medicine used for treating patients with mild to moderate Crohn's disease.